Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

MBD3L1 Inhibitors

MBD3L1 inhibitors encompass a range of compounds that interfere with the DNA methylation landscape, which is crucial for MBD3L1's binding to methylated DNA. Histone deacetylase inhibitors like Trichostatin A and Entinostat can indirectly inhibit MBD3L1 function by remodeling the chromatin structure, making it more accessible and possibly disrupting the usual binding patterns of MBD3L1 to methylated regions. DNA methyltransferase inhibitors, including 5-Aza-2'-deoxycytidine, RG108, and S-Adenosylhomocysteine, decrease the overall methylation level of DNA, which in turn can reduce the binding sites available for MBD3L1, thereby inhibiting its functional activity. These agents, by altering the epigenetic marks, challenge the conventional operating environment for MBD3L1, imposing a state where its typical binding and regulatory roles are compromised. The action of compounds such as Mithramycin A, which binds to GC-rich sequences, and Chloroquine, which intercalates into DNA, could lead to structural alterations in DNA that hinder MBD3L1's ability to interact with its preferred methylated loci. Inhibitors targeting histone methylation, such as BIX-01294, could alter the histone modification patterns at sites where MBD3L1 may exert its function, thus indirectly inhibiting MBD3L1 by changing the epigenetic context of its action. Similarly, flavonoids like Quercetin, which inhibit DNA methyltransferases, and hypomethylating agents such as Decitabine and Zebularine, can inhibit MBD3L1 by reducing the methylation status of DNA.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Histone deacetylase inhibitor that increases acetylation of histones, leading to a more open chromatin structure and often increased transcription. Given MBD3L1's role in chromatin organization, Trichostatin A could lead to the inhibition of MBD3L1's ability to bind methylated DNA by altering the chromatin state.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

DNA methyltransferase inhibitor that reduces DNA methylation. MBD3L1, which binds to methylated DNA, would have fewer binding sites available, potentially decreasing its functional activity.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

DNA methyltransferase inhibitor that prevents DNA methylation without the cytotoxicity of nucleoside analogs. Reduced DNA methylation would decrease MBD3L1's ability to bind to methylated DNA.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Antitumor antibiotic that binds to GC-rich sequences in DNA, possibly preventing MBD3L1 from interacting with its usual binding sites if they overlap with GC-rich regions.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Known as an antimalarial drug, it intercalates into DNA, which could disrupt MBD3L1's ability to bind methylated DNA due to structural interference.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

A flavonoid that is known to inhibit DNA methyltransferases, leading to decreased methylation and potentially decreased MBD3L1 binding to methylated DNA regions.

Histone Lysine Methyltransferase Inhibitor Inhibitor

935693-62-2 (free base)sc-202651
5 mg
$151.00
4
(1)

Histone lysine methyltransferase inhibitor, targeting G9a and GLP, which modifies histones at MBD3L1 binding sites, potentially altering its ability to bind DNA.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

Histone deacetylase inhibitor that can alter chromatin structure, potentially decreasing MBD3L1's ability to bind to its methylated DNA targets effectively.

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$129.00
$284.00
$1004.00
3
(1)

DNA methyltransferase inhibitor that leads to DNA demethylation, potentially reducing MBD3L1's ability to bind its target DNA sequences.

Hydralazine-15N4 Hydrochloride

304-20-1 (unlabeled)sc-490605
1 mg
$480.00
(0)

A vasodilator that can also inhibit DNA methylation, thus potentially reducing MBD3L1's functional activity by decreasing its target DNA methylation levels.